|
[1]
|
R. D. Porsolt, M. Le Pichon and M. Jalfre, “Depression: A
New Animal Model Sensitive to Anti Depressant Treat-
ments,” Nature, Vol. 266, No. 5604, 1977, pp. 730-732.
|
|
[2]
|
F. Borsini and A. Meli, “Is the Forced Swimming Test a
Suitable Model for Revealing Antidepressant Activity?”
Psychopharmacology, Vol. 94, No. 2, 1988, pp. 147-160.
|
|
[3]
|
T. J. Connor, P. Kelliher, Y. Shen, A. Harkin, J. P. Kelly
and B. E. Leonard, “Effect of Subchronic Antidepressant
Treatments on Behavioral, Neurochemical, and Endocrine
Changes in the Forced-Swim Test,” Pharmacology Bio-
chemistry and Behavior, Vol. 65, No. 4, 2000, pp. 591-597.
|
|
[4]
|
M. J. Detke and I. Lucki, “Detection of Serotonergic and
Noradrenergic Antidepressants in the Rat Forced Swim-
ming Test: The Effect of Water Depth,” Behavioural Brain
Research, Vol. 73, No. 1-2, 1996, pp. 43-46.
|
|
[5]
|
R. D. Porsolt, A. Bertin, N. Blavet, M. Deniel and M. Jalfre,
“Immobility Induced by Forced Swimming in Rats: Ef-
fects of Agents which Modify Central Catecholamine and
Serotonin Activity,” European Journal of Pharmacology,
Vol. 57, No. 2-3, 1979, pp. 201-210.
|
|
[6]
|
M. J. Detke, M. Rickels and I. Lucki, “Active Behaviors
in the Rat Forced Swimming Test Differentially Produced
by Serotonergic and Noradrenergic Antidepressants,” Psy-
chopharmacology, Vol. 121, No. 1, 1995, pp. 66-72.
|
|
[7]
|
S. E. Hemby, I. Lucki, G. Gatto, A. Singh, C. Thornley, J.
Matasi, N. Kong, J. E. Smith, H. M. L. Davies and S. I.
Dworkin, “Potential Antidepressant Effects of Novel Tro-
pane Compounds, Selective for Serotonin or Dopamine
Transporters,” Journal of Pharmacology and Experimen-
tal Therapeutics, Vol. 282, No. 2, 1997, pp. 727-733.
|
|
[8]
|
L. G. Kirby and I. Lucki, “Interaction between the Forced
Swimming Test and Fluoxetine Treatment on Extracellu-
lar 5-Hydroxytryptamine and 5-Hydroxyindoleacetic Acid
in the Rat,” Journal of Pharmacology and Experimental
Therapeutics, Vol. 282, No. 2, 1997, pp. 967-976.
|
|
[9]
|
M. E. Page, M. J. Detke, G. Kirby and I. Lucki, “Sero-
tonergic Mediation of the Effects of Fluoxetine, but not
Desipramine, in the Rat Forced Swimming Test,” Psy-
chopharmacology, Vol. 147, No. 2, 1999, pp. 162-167.
|
|
[10]
|
J. P. Reneric and I. Lucki, “Antidepressant Behavioral
Effects by Dual Inhibition of Monoamine Reuptake in the
Rat Forced Swimming Test,” Psychopharmacology, Vol.
136, No. 2, 1998, pp. 190-197.
|
|
[11]
|
C. L?pez-Rubalcava and I. Lucki, “Strain Differences in
the Behavioral Effects of Antidepressant Drugs in the Rat
Forced Swimming Test,” Neuropsychopharmacology, Vol.
22, No. 2, 2000, pp. 191-199.
|
|
[12]
|
T. Skrebuhhova, L. Allikmets and V. Matto, “Effect of
Anxiogenic Drugs in Rat Forced Swimming Test,” Meth-
ods & Findings in Experimental & Clinical Pharmacol-
ogy, Vol. 21, No. 3, 1999, pp. 173-178.
|
|
[13]
|
J. De Vry, S. Maurel, R. Schreiber, R. de Beun and K. R.
Jentzsch, “Comparison of Hypericum Extracts with Imi-
pramine and Fluoxetine in Animal Models of Depression
and Alcoholism,” European Neuropsychopharmacology,
Vol. 9, No. 6, 1999, pp. 461-468.
|
|
[14]
|
G. Griebel, C. Cohen, G. Perrault and D. J. Sanger, “Be-
havioral Effects of Acute and Chronic Fluoxetine in Wis-
tar-Kyoto Rats,” Physiology & Behavior, Vol. 67, No. 3,
1999, pp. 315-320.
|
|
[15]
|
J. F. Cryan, M. E. Page and I. Lucki, “Differential Be-
havioral Effects of the Antidepressants Reboxetine, Fluo-
xetine, and Moclobemide in a Modified Forced Swim
Test Following Chronic Treatment,” Psychopharmacol-
ogy (Berl), Vol. 182, No. 3, 2005, pp. 335-339.
|
|
[16]
|
S. Dal-Zotto, O. Marti and A. Armario, “Influence of
Single or Repeated Experience of Rats with Forced Swim-
ming on Behavioral and Physiological Responses to the
Stressor,” Behavioural Brain Research, Vol. 114, No. 1-2,
2000, pp. 175-181.
|
|
[17]
|
L. G. Kirby and I. Lucki, “The Effect of Repeated Expo-
sure to Forced Swimming on Extracellular Levels of
5-Hydroxytryptamine in the Rat,” Stress, Vol. 2, No. 4,
1998, pp. 251-263.
|
|
[18]
|
A. Parra, C. Vinader-Caerols, S. Monle?n and V. M. Sim?n,
“Learned Immobility is also Involved in Forced Swim-
ming Test in Mice,” Psicothema, Vol. 11, No. 2, 1999, pp.
239-246.
|
|
[19]
|
Y. Lamberty and A. J. Gower, “Cholinergic Modulation
of Spatial Learning in Mice in a Morris-Type Water
Maze,” Archives Internationales de Pharmacodynamie et
de Therapie, Vol. 309, 1991, pp. 5-19.
|
|
[20]
|
G. Richter-Levin and M. Segal, “The Effect of Serotonin
Depletion and Raphe Grafts on Hippocampal Electro-
physiology and Behavior,” Journal of Neuroscience, Vol.
11, No. 6, 1991, pp. 1585-1596.
|
|
[21]
|
J. M. De Pablo, A. Parra, S. Segovia and A. Guillamon,
“Learned Immobility Explains the Behavior of Rats in the
Forced Swimming Test,” Physiology & Behavior, Vol. 46,
No. 2, 1989, pp. 229-237.
|
|
[22]
|
A. J. Martos, C. Vinader-Caerols, S. Monle?n, M. C. Are-
nas and A. Parra, “Effect of Physostigmine and Nicotine
on Learned Immobility in the Forced Swimming Test,”
Psicothema, Vol. 11, No. 3, 1999, 631-639.
|
|
[23]
|
E. H. Cook, K. E. Fletcher, M. Wainwright, N. Marks, S.
Y. Yan and B. L. Leventhal, “Primary Structure of the
Human Platelet Serotonin 5-HT2A Receptor: Identity with
Frontal Cortex Serotonin 5-HT2A Receptor,” Journal of
Neurochemistry, Vol. 63, No. 2, 1994, pp. 465-469.
|
|
[24]
|
C. R. Pfeffer, P. A. McBride, G. M. Anderson, T. Ka-
kuma, L. Fensterheim and V. Khait, “Peripheral Sero-
tonin Measures in Prepubertal Psychiatric Inpatients and
Normal Children: Association with Suicidal Behavior and
its Risk Factors,” Biological Psychiatry, Vol. 44, No. 7,
1988, pp. 568-577.
|
|
[25]
|
S. D. Mendelson, “The Current Status of the Platelet
5-HT2A
Receptor in Depression,” Journal of Affective
Disorders, Vol. 57, No. 1, 2000, pp. 13-24.
|
|
[26]
|
J. M. Sneddon, “Blood Platelets as a Model for Mono-
amine Containing Neurones,” Progress in Neurobiology,
Vol. 1, No. 2, 1973, pp. 151-198.
|
|
[27]
|
S. M. Stahl, “The Human Blood Platelet: A Diagnostic
and Research Tool for the Study of Biogenic Amines in
Psychiatric and Neurologic Disorders,” Archives of Gen-
eral Psychiatry, Vol. 34, No. 5, 1977, pp. 509-516.
|
|
[28]
|
M. Bianchi, C. Moser, C. Lazzarini, E. Vecchiato and F.
Crespi, “Forced Swimming Test and Fluoxetine Treat-
ment: In Vivo Evidence that Peripheral 5-HT in Rat
Platelet-Rich Plasma Mirrors Cerebral Extracellular 5-HT
Levels, whilst 5-HT in Isolated Platelets Mirrors Neu-
ronal 5-HT Changes,” Experimental Brain Research, Vol.
143, No. 2, 2002, pp. 191-197.
|
|
[29]
|
F. Congestri, F. Formenti, V. Sonntag and F. Crespi, “The
Selective D3 Receptor Antagonist SB-277011-A Potenti-
ates the Effect of Cocaine on Extracellular Dopamine in
the Nucleus Accumbens: A Dual Core-Shell Voltammetry
Study in Anesthetized Rats,” Sensors, Vol. 8, No. 11, 2008,
pp. 6936-6951.
|
|
[30]
|
F. Crespi, “In Vivo Voltammetry with Micro-Biosensors
for Analysis of Neurotransmitter Release and Metabo-
lism,” Journal of Neuroscience Methods, Vol. 34, No. 1-3,
1990, pp. 53-65.
|
|
[31]
|
F. Crespi, K. F. Martin and C. A. Marsden, “Measurement
of Extracellular Basal Levels of Serotonin in Vivo Using
Nafion-Coated Carbon Fibre Electrodes Combined with
Differential Pulse Voltammetry,” Neuroscience, Vol. 27,
No. 3, 1988, pp. 885-896.
|
|
[32]
|
J.-M. Zen, I.-L. Chen and Y. Shih, “Voltammetric Deter-
mination of Serotonin in Human Blood Using a Chemi-
cally Modified Electrode,” Analytica Chimica Acta, Vol.
369, No. 1-2, 1998, pp. 103-108.
|
|
[33]
|
F. Crespi, “In Vivo Voltammetry and Concomitant Elec-
trophysiology at a Single Biosensor to Analyse Ischaemia,
Depression and Drug Dependence,” Journal of Neuro-
science Methods, Vol. 119, No. 2, 2002, pp. 173-184.
|
|
[34]
|
F. Crespi and M. Jouvet, “Differential Pulse Voltammetry
Parallel Peak 3 Changes with Vigilance States in Raphe
Dorsalis and Raphe Magnus of Chronic Freely Moving
Rats and Evidence for 5HT Contribution to this Peak after
Monoamine Oxidase Inhibitors,” Brain Research, Vol. 272,
No. 2, 1983, pp. 263-268.
|
|
[35]
|
A. Louilot, A. Serrano and M. D’Angio, “A Novel Car-
bon Fiber Implantation Assembly for Cerebral Voltam-
metric Measurements in Freely Moving Rats,” Physiology
& Behavior, Vol. 41, No. 3, 1987, pp. 227-231.
|
|
[36]
|
S. L. Handley and J. W. McBlane, “Opposite Effects of
Fluoxetine in Two Animal Models of Anxiety,” British
Journal of Pharmacology, Vol. 107S, 1997, p. 446.
|
|
[37]
|
M. L. Rao, B. Hawellek, A. Papassotiropoulos, A. Deister
and C. Frahnert, “Upregulation of the Platelet Serotonin2A
Receptor and Low Blood Serotonin in Suicidal Psychiat-
ric Patients,” Neuropsychobiology, Vol. 38, No. 2, 1998,
pp. 84-89.
|
|
[38]
|
F. Crespi, “Apamin Increases 5-HT Cell Firing in Raphe
Dorsalis and Extracellular 5-HT Levels in Amygdala: A
Concomitant in Vivo Study in Anesthetized Rats,” Brain
Research, Vol. 1281, 2009, pp. 35-46.
|
|
[39]
|
K. F. Martin, C. A. Marsden and F. Crespi. “In Vivo
Electrochemistry with Carbon Fibre Electrodes: Princi-
ples and Application to Neuropharmacology,” Trends in
Analytical Chemistry, Vol. 7, No. 9, 1988, pp. 334-339.
|
|
[40]
|
J. A. Stamford, F. Crespi and C. A. Marsden, “In Vivo
Voltammetric Methods for Monitoring Monoamine Re-
lease and Metabolism,” Monitoring Neuronal Activity, a
Practical Approach, Oxford University Press, Oxford,
1992, pp. 113-145.
|
|
[41]
|
T Self and F. Crespi, “Electron Microscopic and Volt-
ammetric Analysis of Carbon Fibre Electrode Pretreat-
ments,” Journal of Materials Science: Materials in Medi-
cine, Vol. 3, No. 6, 1992, pp. 418-425.
|
|
[42]
|
F. Crespi and Z. L. Rossetti, “Pulse of Nitric Oxide Re-
lease in Response to Activation of N-Methyl-D-Aspartate
Receptors in the Rat Striatum: Rapid Desensitisation, In-
hibition by Receptor Antagonists and Potentiation by
Glycine,” Journal of Pharmacology and Experimental
Therapeutics, Vol. 309, No. 2, 2004, pp. 462-468.
|
|
[43]
|
F. Crespi, T. Sharp, N. Maidment and C. A. Marsden,
“Differential Pulse Voltammetry in Vivo–Evidence that
Uric Acid Contributes to the Indole Oxidation Peak,”
Neuroscience Letters, Vol. 43, No. 2-3, 1983, pp. 203-207.
|
|
[44]
|
F. Crespi, T. Sharp, N. Maidment and C. A. Marsden, “Dif-
ferential Pulse Voltammetry: Simultaneous in Vivo Meas-
urement of Ascorbic Acid, Catechols and 5-Hydroxyindoles
in the Rat Striatum Using a Single Carbon Fibre Elec-
trode,” Brain Research, Vol. 322, No. 1, 1984, pp. 135-
138.
|
|
[45]
|
F. Crespi, P. Keane and M. Morre, “Does Concomitant
Analysis of Extracellular DOPAC and 5HIAA with a Sin-
gle Carbon Fibre Electrode Enable the Detection of Stri-
atal Dopamine-Serotonin Interaction?” Journal of Neu-
rochemistry, 1985, Vol. 44, pp. 109-112.
|
|
[46]
|
F. Borsini, “Role of the Serotonergic System in the Forced
Swimming Test,” Neuroscience & Biobehavioral Reviews, Vol. 19, No. 3, 1995, pp. 377-395.
|
|
[47]
|
W. F. Boyer and J. P. Feighner, “Side Effects of the Se-
lective Serotonin Re-Uptake Inhibitors,” In: J. P. Feigh-
ner and W. F. Boyer, Ed., Selective Serotonin Re-Uptake
Inhibitors. Perspectives in Psychiatry 1, Wiley Press, New
York, 1991, pp. 133-152.
|
|
[48]
|
P. Chopin and M. Briley, “Animal Models of Anxiety:
The Effect of Compounds that Modify 5-HT Neurotrans-
mission,” Trends in Pharmacological Sciences, Vol. 8,
No. 10, 1987, pp. 383-388.
|
|
[49]
|
F. Borsini, A. Lecci, A. Sessarego, R. Frassine and A.
Meli, “Discovery of Antidepressant Activity by Forced
Swimming Test may Depend on Pre-Exposure of Rats to
a Stressful Situation,” Psychopharmacology, Vol. 97, No.
2, 1989, pp. 183-188.
|
|
[50]
|
C. Barja-Fidalgo, J. A. Guimaraes and C. R. Carlini, “The
Secretory Effect of Canatoxin on Rat Brain Synaptosomes
Involves A Lipoxygenase-Mediated Pathway,” Brazilian
Journal of Medical and Biological Research, Vol. 21, No.
3, 1988, pp. 549-552.
|
|
[51]
|
R. M. Lyons and J. O. Shaw, “Interaction of Ca
2+
and
Protein Phosphorylation in the Rabbit Platelet Release
Reaction,” Journal of Clinical Investigation, Vol. 65, No.
2, 1980, pp. 242-255.
|
|
[52]
|
H. C. Buhot, S. Martin and L. Segu, “Role of Serotonin in
Memory Impairment,” Annals of Medicine, Vol. 32, No. 3,
2000, pp. 210-221.
|
|
[53]
|
W. J. McEntee and T. H. Crook, “Serotonin, Memory,
and the Aging Brain,” Psychopharmacology, Vol. 103, No.
2, 1991, pp. 143-149.
|
|
[54]
|
I. Gonzalez-Burgos, M. I. Perez-Vega, A. R. Del Angel-
Meza and A. Feria-Velasco, “Effect of Tryptophan Re-
striction on Short-Term Memory,” Physiology & Behav-
ior, Vol. 63, No. 2, 1998, pp. 165-169.
|
|
[55]
|
G. T. Shishkina, T. S. Kalinina and N. N. Dygalo, “Sero-
tonergic Changes Produced by Repeated Exposure to
Forced Swimming: Correlation with Behavior,” Annals of
the New York Academy of Sciences, Vol. 1148, 2008, pp.
148-153.
|
|
[56]
|
M. H. Maes and Y. Meltzer, “The Serotonin Hypothesis
of Major Depression,” In: F. E. Bloom and D. J. Kupfer,
Ed., Psychopharmacology: The Fourth Generation of Pro-
gress, Raven Press, New York, 1995, pp. 933-944.
|
|
[57]
|
F. Chaouloff, “Physiopharmacological Interactions between
Stress Hormones and Central Serotonergic Systems,” Brain
Research Reviews, Vol. 18, No. 1, 1993, pp. 1-32.
|
|
[58]
|
L. E. Rueter, C. A. Fornal and B. L. Jacobs, “A Critical
Review of 5-HT Brain Microdialysis and Behavior,” Re-
views in the Neurosciences, Vol. 8, No. 2, 1997, pp. 117-137.
|
|
[59]
|
R. K. McNamara and R. W. Skelton, “The Neurophar-
macological and Neurochemical Basis of Place Learning
in the Morris Water Maze,” Brain Research Reviews, Vol.
18, No. 1, 1993, pp. 33-49.
|
|
[60]
|
S. Tejani-Butt, J. Kluczynski and W. P. Paré, “Strain-
Dependent Modification of Behavior Following Antide-pressant Treatment,” Progress in Neuro-Psychopharma-
cology & Biological Psychiatry, Vol. 27, No. 1, 2003, pp.
7-14.
|
|
[61]
|
O. Malkesman, Y. Braw, R. Maayan, A. Weizman, D. H.
Overstreet, M. Shabat-Simon, Y. Kesner, et al., “Two
Different Putative Genetic Animal Models of Childhood
Depression,” Biological Psychiatry, Vol. 59, No. 1, 2006,
pp. 17-23.
|
|
[62]
|
B. L. Roth, S. M. Hanizavareh and A. E. Blum, “Sero-
tonin Receptors Represent Highly Favorable Molecular
Targets for Cognitive Enhancement in Schizophrenia and
Other Disorders,” Psychopharmacology, Vol. 174, No. 1,
2004, pp. 17-24.
|
|
[63]
|
E. S. Mitchell and J. F. Neumaier, “5-HT6 Receptors: A
Novel Target for Cognitive Enhancement,” Pharmacol-
ogy & Therapeutics, Vol. 108, No. 3, 2005, pp. 320-333.
|
|
[64]
|
R. Schreiber, A. J. Sleight and M. L. Woolley, “5-HT6
Receptors as Targets for the Treatment of Cognitive
Deficits in Schizophrenia,” In: B. R. Roth, Ed., Serotonin
Receptors: From Molecular Pharmacology to Human Ther-
apeutics, Humana Press, Totowa, 2006, pp. 495-515.
|
|
[65]
|
E. S. Mitchell, B. J. Hoplight, S. P. Lear and J. F. Neu-
maier, “BGC20-761, a Novel Tryptamine Analog, En-
hances Memory Consolidation and Reverses Scopola-
mine-Induced Memory Deficit in Social and Visuospatial
Memory Tasks through a 5-HT6 Receptor-Mediated Me-
chanism,” Neuropharmacology, Vol. 50, No. 4, 2006, pp.
412-420.
|